MedTrace Logo

Evaluating the Effectiveness of a Drug Education and Diversion Program for Middle and High School Students

NCT05321563 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 132

Last updated 2024-12-05

No results posted yet for this study

Summary

The primary goal of this study is to evaluate the effectiveness of the iDECIDE curriculum as an alternative to punitive responses for school-based substance use infractions.

Conditions

  • Adolescent Behavior
  • Substance Use
  • Youth
  • Health Risk Behaviors

Interventions

BEHAVIORAL

iDECIDE (Drug Education Curriculum: Intervention, Diversion, and Empowerment)

iDECIDE is a 4 session curriculum that addresses topics such as the neurobiology of substance use, adolescent brain development, industry tactics, motivations for using substances, risk and protective factors, triggers, healthy alternatives, core values, and long-term goal setting. These topics are taught via facilitated discussions, videos, worksheets, and handouts. Facilitators are selected by schools and community agencies to receive free trainings conducted by the iDECIDE team, which includes personnel from the Massachusetts Department of Public Health, Massachusetts General Hospital (MGH) Center for Addiction Medicine, and the Institute for Health and Recovery.

Sponsors & Collaborators

  • Massachusetts Department of Health

    collaborator OTHER_GOV

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Randi M Schuster, PhD · Massachusetts General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-04
Primary Completion
2023-09-14
Completion
2023-09-14

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05321563 on ClinicalTrials.gov